131 related articles for article (PubMed ID: 591144)
1. Prospects, problems, side effects, and safety of narcotic antagonists.
Resnick RB
Int J Addict; 1977 Oct; 12(7):863-7. PubMed ID: 591144
[TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone and cyclazocine. A controlled treatment study.
Brahen LS; Capone T; Wiechert V; Desiderio D
Arch Gen Psychiatry; 1977 Oct; 34(10):1181-4. PubMed ID: 911218
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the National Academy of Sciences study of naltrexone.
Kaim SC
NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
[No Abstract] [Full Text] [Related]
5. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
Hanlon TE; McCabe OL; Savage C; Kurland AA
Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
[TBL] [Abstract][Full Text] [Related]
6. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
7. The double-blind crossover trial design: how good is it for psychoactive drugs?
Brahen LS; Capone T; Wojak JC
Am J Drug Alcohol Abuse; 1979; 6(2):189-96. PubMed ID: 517491
[No Abstract] [Full Text] [Related]
8. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
9. Clinical experiences with narcotic antagonists: cyclazocine and naloxone.
Proc Natl Conf Methadone Treat; 1973; 1():447-51. PubMed ID: 4808183
[No Abstract] [Full Text] [Related]
10. Clinical experiences with naltrexone in 370 detoxified addicts.
Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
[TBL] [Abstract][Full Text] [Related]
11. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
12. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
[No Abstract] [Full Text] [Related]
13. Historical perspective on the chemistry and development of naltrexone.
Archer S
NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
[TBL] [Abstract][Full Text] [Related]
14. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
15. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.
NIDA Res Monogr; 1981; 28():1-273. PubMed ID: 6790998
[No Abstract] [Full Text] [Related]
16. Narcotic antagonists: a reasonable method of treating narcotic dependency.
Schooff KG; Hersch RG; Keegan JF
Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227
[TBL] [Abstract][Full Text] [Related]
17. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
18. Insoluble salts and salt complexes of cyclazocine and naloxone.
Gray AP; Robinson DS
Adv Biochem Psychopharmacol; 1973; 8(0):555-68. PubMed ID: 4800171
[No Abstract] [Full Text] [Related]
19. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
Lewis DC
Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
[No Abstract] [Full Text] [Related]
20. The development of sustained action preparations of narcotic antagonists.
Willette RE
NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
